Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Drug-combination wide association studies of cancer

medRxiv(2022)10.1101/2022.09.29.22280479Source: DataRank Database

Drug-combination wide association studies of cancer is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (5)IDs (PubMed)SDGs (1)

Context only (not used in score)

Findable (1/2)

Accessible (1/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

We only score data papers we can read in full — never from an abstract alone.

Live enrichment

National Institutes of Health

Grant: 5K01ES028055-03

Using clinical data to identify FDA-approved drugs for cancer prevention and therapeutic repurposing

National Institutes of Health

Grant: 5R35GM151001-03

Integrating genetics and health data to discover common drug effects on cancer and Alzheimer's disease

greenLicense: cc-by-nc

Fields of Study

03 medical and health sciences0302 clinical medicine0101 mathematics01 natural sciences

Keywords

Article

Sustainable Development Goals

SDG 3: 3. Good health